GGrantIndex
← Leaderboards

Jason Hansen Karnes

University Of Arizona

$5,620,392
Attributed
$7,693,150
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY201925
$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,693,150 · 5

By mechanism

R01$4,117,014 · 2
OT2$2,552,532 · 1
K01$615,220 · 1
R21$408,384 · 1

Most similar at University Of Arizona

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Public Health

Research focus

Public HealthUnited States National Institutes Of HealthMissionVariantGenesCardiovascular DiseasesAdverse Drug ReactionCohortPharmacogenomicsInnovationPopulation HeterogeneityGeneticInvestigationGenome Wide Association StudyGenomicsPathogenesisAffectMediatingImmuneGenotypeBiologicalAnticoagulantsAllelesClinical Research

Grant awards (19)

Precision Medicine for All of Us Researchers Collective$550,000
OT2 · FY2025 · OD · contact PI
ABO and Immunogenetic Variation in the Pathogenesis of Heparin-Induced Thrombocytopenia$540,699
R01 · FY2025 · HL · contact PI
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients$400,260
R01 · FY2025 · HL · contact PI
Precision Medicine for All of Us Researchers’ Collective$999,916
OT2 · FY2024 · OD · contact PI
ABO and Immunogenetic Variation in the Pathogenesis of Heparin-Induced Thrombocytopenia$529,885
R01 · FY2024 · HL · contact PI
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients$392,255
R01 · FY2024 · HL · contact PI
Discovery of Immunogenomic Associations with Disease and Differential Risk Across Diverse Populations$184,740
R21 · FY2024 · HL · contact PI
Precision Medicine for All of Us Researchers Collective Medicine de Precision: Colectivo de Investigadores Salud para Todos$1,002,616
OT2 · FY2023 · OD · contact PI
ABO and Immunogenetic Variation in the Pathogenesis of Heparin-Induced Thrombocytopenia$436,088
R01 · FY2023 · HL · contact PI
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients$394,580
R01 · FY2023 · HL · contact PI
Discovery of Immunogenomic Associations with Disease and Differential Risk Across Diverse Populations$223,644
R21 · FY2023 · HL · contact PI
ABO and Immunogenetic Variation in the Pathogenesis of Heparin-Induced Thrombocytopenia$457,272
R01 · FY2022 · HL · contact PI
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients$440,016
R01 · FY2022 · HL · contact PI
Genomic and Transcriptomic Influences on Heparin-Induced Thrombocytopenia$153,805
K01 · FY2022 · HL · contact PI
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients$106,845
R01 · FY2022 · HL · contact PI
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients$419,114
R01 · FY2021 · HL · contact PI
Genomic and Transcriptomic Influences on Heparin-Induced Thrombocytopenia$153,805
K01 · FY2021 · HL · contact PI
Genomic and Transcriptomic Influences on Heparin-Induced Thrombocytopenia$153,805
K01 · FY2020 · HL · contact PI
Genomic and Transcriptomic Influences on Heparin-Induced Thrombocytopenia$153,805
K01 · FY2019 · HL · contact PI